32.85
Ideaya Biosciences Inc Azioni (IDYA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
35.02%
8.857
|
6.56 | 10.88 | 207.83 | - |
| Operating Expenses |
13.94%
131.15
|
115.10 | 105.45 | 99.38 | 88.81 |
| Depreciation and Amortization |
0.00%
0.70
|
0.70 | 0.70 | 0.70 | 0.70 |
| Operating Income/Loss |
12.66%
-122.29
|
-108.54 | -94.57 | 108.45 | -88.81 |
| Nonoperating Income/Loss |
1.66%
9.839
|
10.01 | 11.30 | 10.79 | 11.31 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
14.12%
-112.45
|
-98.54 | -83.27 | 119.24 | -77.49 |
| Basic Average Shares |
3.79%
92.06
|
88.70 | 0.0328 | 88.53 | 88.47 |
| Diluted Average Shares |
3.79%
92.06
|
88.70 | 0.0328 | 89.69 | 88.47 |
| Basic Earnings Per Share |
9.91%
-1.22
|
-1.11 | -0.94 | 1.35 | -0.88 |
| Diluted Earnings Per Share |
9.91%
-1.22
|
-1.11 | -0.94 | 1.33 | -0.88 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):